Raymond James Financial »

Cogent Biosciences shares owned by Raymond James Financial

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.2M 289k 14.36
2025-06-30 $323 45 7.18

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Cogent Biosciences

FMR
BlackRock
Deerfield Management Company
Fairmount Funds Management
Kynam Capital Management
Vanguard Group
Commodore Capital
TCG Crossover Management
State Street Corporation
VR Adviser
Rtw Investments
Geode Capital Management
Henderson Group
Paradigm Biocapital Advisors
Octagon Capital Advisors

View all funds holding Cogent Biosciences